Literature DB >> 11755554

Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses.

L B Signorello1, A Nordmark, F Granath, W J Blot, J K McLaughlin, G Annerén, S Lundgren, A Ekbom, A Rane, S Cnattingius.   

Abstract

OBJECTIVE: To investigate whether the rate of caffeine metabolism influences spontaneous abortion risk.
METHODS: We studied 101 women with normal karyotype spontaneous abortions and 953 pregnant women at 6-12 gestational weeks. Participants reported on caffeine intake and provided urine for phenotyping cytochrome P4501A2 (CYP1A2) activity and blood for genotyping N-acetylation (NAT2) status. We calculated odds ratios (OR) and 95% confidence intervals (CI) to evaluate the association between each of the two metabolic indices and spontaneous abortion risk and also the potential interaction between caffeine intake and metabolic activity on such risk. In calculating the associations between the metabolic indices and risk of spontaneous abortion, we had 80% power to detect an OR of 2.1, with a Type I error of 0.05.
RESULTS: Slow acetylators had a nonsignificantly increased risk for spontaneous abortion (OR 1.36, 95% CI 0.84, 2.21) and recurrent spontaneous abortion (OR 2.51, 95% CI 0.81, 7.76). In contrast, low CYP1A2 activity was associated with a significantly decreased risk for spontaneous abortion (OR 0.35, 95% CI 0.20, 0.63). Caffeine was a risk factor for spontaneous abortion among women with high, but not low, CYP1A2 activity (OR 2.42, 95% CI 1.01, 5.80 for 100-299 mg/day; OR 3.17, 95% CI 1.22, 8.22 for 300 mg/day or more, among women with high CYP1A2 activity).
CONCLUSION: The findings indicate that high CYP1A2 activity may increase the risk of spontaneous abortion, independently or by modifying the effect of caffeine. The results regarding NAT2 are less conclusive but suggest that slow acetylators may be at elevated risk of spontaneous abortion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11755554     DOI: 10.1016/s0029-7844(01)01575-7

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

1.  The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women.

Authors:  Anna Nordmark; Stefan Lundgren; Birgitta Ask; Fredrik Granath; Anders Rane
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

2.  PharmGKB summary: caffeine pathway.

Authors:  Caroline F Thorn; Eleni Aklillu; Ellen M McDonagh; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-05       Impact factor: 2.089

3.  Caffeine, selected metabolic gene variants, and risk for neural tube defects.

Authors:  Rebecca J Schmidt; Paul A Romitti; Trudy L Burns; Jeffrey C Murray; Marilyn L Browne; Charlotte M Druschel; Richard S Olney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-07

Review 4.  Impacts of Caffeine during Pregnancy.

Authors:  Jingjing Qian; Qi Chen; Sean M Ward; Enkui Duan; Ying Zhang
Journal:  Trends Endocrinol Metab       Date:  2019-12-06       Impact factor: 12.015

Review 5.  Evaluation of the reproductive and developmental risks of caffeine.

Authors:  Robert L Brent; Mildred S Christian; Robert M Diener
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2011-03-02

6.  Caffeine consumption during early pregnancy impairs oviductal embryo transport, embryonic development and uterine receptivity in mice.

Authors:  Jingjing Qian; Yunfang Zhang; Yongcun Qu; Liwen Zhang; Junchao Shi; Xudong Zhang; Shichao Liu; Bo Hyun Kim; Sung Jin Hwang; Tong Zhou; Qi Chen; Sean M Ward; Enkui Duan; Ying Zhang
Journal:  Biol Reprod       Date:  2018-12-01       Impact factor: 4.285

7.  Interaction between maternal caffeine intake during pregnancy and CYP1A2 C164A polymorphism affects infant birth size in the Hokkaido study.

Authors:  Seiko Sasaki; Mariko Limpar; Fumihiro Sata; Sumitaka Kobayashi; Reiko Kishi
Journal:  Pediatr Res       Date:  2017-05-24       Impact factor: 3.756

8.  Embryonic caffeine exposure induces adverse effects in adulthood.

Authors:  Christopher C Wendler; Melissa Busovsky-McNeal; Satish Ghatpande; April Kalinowski; Kerry S Russell; Scott A Rivkees
Journal:  FASEB J       Date:  2008-12-16       Impact factor: 5.191

9.  Caffeine acts via A1 adenosine receptors to disrupt embryonic cardiac function.

Authors:  Daniela L Buscariollo; Gregory A Breuer; Christopher C Wendler; Scott A Rivkees
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

Review 10.  Association of maternal caffeine intake during pregnancy with low birth weight, childhood overweight, and obesity: a meta-analysis of cohort studies.

Authors:  Feng Jin; Chong Qiao
Journal:  Int J Obes (Lond)       Date:  2020-06-09       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.